title: Regulating Homeopathic Products - A Century of Dilute Interest.
abstract: In 2015, U.S. government agencies began considering greater regulation of both homeopathic drugs and the advertising of such products. These actions came after more than a century of missed opportunities to regulate homeopathic medicines.
authors.affiliation: From the Department of Global Health and Social Medicine, Harvard Medical School (S.H.P.), and the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - both in Boston.
authors.forename: Scott H
authors.initials: SH
authors.lastname: Podolsky
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D033161:Government Regulation / Q000266:history; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006705:Homeopathy / Q000266:history*; D007880:Legislation, Drug / Q000266:history*; D008419:Materia Medica / Q000266:history* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history
chemical_list: D008419:Materia Medica